Santhera Pharmaceuticals (SWX:SANN) was informed by Cominvest Asset Management GmbH, Ulrich Talmann, Platz der Einheit 1, DE-60327 Frankfurt am Main, Germany, that the public and non-public funds under its management together hold 148,178 registered shares of Santhera Pharmaceuticals Holding AG, representing 4.78% of the voting rights of the shares registered in the Commercial Register. The disclosure was made in accordance with the revised provisions of the SESTA.
* * *
For further information, contact
Thomas Staffelbach, VP Public & Investor Relations
Phone +41 (0)61 906 89 47
